You Position: Home > Paper

Influence of pioglitazone and metformin on serum adiponectin level in patients with type 2 diabetes mellitus

( views:221, downloads:55 )
Author:
No author available
Journal Title:
Chinese Journal of Diabetes
Issue:
9
DOI:
10.3969/j.issn.1006-6187.2012.09.008
Key Word:
糖尿病,2型;脂联素;吡格列酮;二甲双胍;肥胖

Abstract: 目的 探讨吡格列酮和二甲双胍治疗对肥胖T2DM患者血清APN的不同影响. 方法将48例新诊断的肥胖T2DM患者随机分两组,分别给予二甲双胍(M组)和二甲双胍联合吡格列酮(MP 组)治疗12周;于治疗前后测定受试者空腹血清APN、FPG、HbA1c、血脂、FIns,计算BMI、胰岛素抵抗指数(HOMA-IR). 结果 与治疗前相比,MP组APN水平明显升高(P=0.0005),MP组FPG、HbA1c、HOMA-IR、BMI、FIns明显降低(P<0.05);与治疗前相比,M组APN水平无明显改变(P=0.487),BMI、FPG、HbA1c、HOMA-IR、FIns、LDL-C明显降低(P<0.05). 结论 吡格列酮能有效增加肥胖T2DM患者血清APN水平.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn